Nonalcoholic Fatty Liver Disease: An Underrecognized Cause of Cryptogenic Cirrhosis

Jeanne Clark, Anna Mae Diehl

Research output: Contribution to journalArticle

Abstract

Cryptogenic cirrhosis is a common cause of liver-related morbidity and mortality in the United States. Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of cryptogenic cirrhosis. However, the diagnosis of cirrhosis in patients with NAFLD appears to be delayed compared with those with other chronic liver diseases and thus carries a higher mortality rate. This delay in diagnosis is illustrated in our case of a 53-year-old man who presented with hepatic hydrothorax and ascites, whose workup revealed cirrhosis due to NAFLD. Although a diagnosis of presumed NAFLD can be made noninvasively, a definitive diagnosis requires a liver biopsy specimen. A biopsy specimen is also important for detecting histologically advanced disease, which may be clinically silent and undetected by amino-transferases or diagnostic imaging. Although there are no proven treatments, recommendations for patients with NAFLD include avoidance of hepatotoxins and aggressive management of associated conditions, such as hypertriglyceridemia and type 2 diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)3000-3004
Number of pages5
JournalJournal of the American Medical Association
Volume289
Issue number22
DOIs
StatePublished - Jun 11 2003

Fingerprint

Liver
Fibrosis
Hydrothorax
Biopsy
Mortality
Hypertriglyceridemia
Diagnostic Imaging
Transferases
Ascites
Type 2 Diabetes Mellitus
Liver Diseases
Chronic Disease
Cryptogenic Cirrhosis
Non-alcoholic Fatty Liver Disease
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nonalcoholic Fatty Liver Disease : An Underrecognized Cause of Cryptogenic Cirrhosis. / Clark, Jeanne; Diehl, Anna Mae.

In: Journal of the American Medical Association, Vol. 289, No. 22, 11.06.2003, p. 3000-3004.

Research output: Contribution to journalArticle

@article{e9f83b03766a444cbb3441c5e9980ed9,
title = "Nonalcoholic Fatty Liver Disease: An Underrecognized Cause of Cryptogenic Cirrhosis",
abstract = "Cryptogenic cirrhosis is a common cause of liver-related morbidity and mortality in the United States. Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of cryptogenic cirrhosis. However, the diagnosis of cirrhosis in patients with NAFLD appears to be delayed compared with those with other chronic liver diseases and thus carries a higher mortality rate. This delay in diagnosis is illustrated in our case of a 53-year-old man who presented with hepatic hydrothorax and ascites, whose workup revealed cirrhosis due to NAFLD. Although a diagnosis of presumed NAFLD can be made noninvasively, a definitive diagnosis requires a liver biopsy specimen. A biopsy specimen is also important for detecting histologically advanced disease, which may be clinically silent and undetected by amino-transferases or diagnostic imaging. Although there are no proven treatments, recommendations for patients with NAFLD include avoidance of hepatotoxins and aggressive management of associated conditions, such as hypertriglyceridemia and type 2 diabetes mellitus.",
author = "Jeanne Clark and Diehl, {Anna Mae}",
year = "2003",
month = "6",
day = "11",
doi = "10.1001/jama.289.22.3000",
language = "English (US)",
volume = "289",
pages = "3000--3004",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "22",

}

TY - JOUR

T1 - Nonalcoholic Fatty Liver Disease

T2 - An Underrecognized Cause of Cryptogenic Cirrhosis

AU - Clark, Jeanne

AU - Diehl, Anna Mae

PY - 2003/6/11

Y1 - 2003/6/11

N2 - Cryptogenic cirrhosis is a common cause of liver-related morbidity and mortality in the United States. Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of cryptogenic cirrhosis. However, the diagnosis of cirrhosis in patients with NAFLD appears to be delayed compared with those with other chronic liver diseases and thus carries a higher mortality rate. This delay in diagnosis is illustrated in our case of a 53-year-old man who presented with hepatic hydrothorax and ascites, whose workup revealed cirrhosis due to NAFLD. Although a diagnosis of presumed NAFLD can be made noninvasively, a definitive diagnosis requires a liver biopsy specimen. A biopsy specimen is also important for detecting histologically advanced disease, which may be clinically silent and undetected by amino-transferases or diagnostic imaging. Although there are no proven treatments, recommendations for patients with NAFLD include avoidance of hepatotoxins and aggressive management of associated conditions, such as hypertriglyceridemia and type 2 diabetes mellitus.

AB - Cryptogenic cirrhosis is a common cause of liver-related morbidity and mortality in the United States. Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of cryptogenic cirrhosis. However, the diagnosis of cirrhosis in patients with NAFLD appears to be delayed compared with those with other chronic liver diseases and thus carries a higher mortality rate. This delay in diagnosis is illustrated in our case of a 53-year-old man who presented with hepatic hydrothorax and ascites, whose workup revealed cirrhosis due to NAFLD. Although a diagnosis of presumed NAFLD can be made noninvasively, a definitive diagnosis requires a liver biopsy specimen. A biopsy specimen is also important for detecting histologically advanced disease, which may be clinically silent and undetected by amino-transferases or diagnostic imaging. Although there are no proven treatments, recommendations for patients with NAFLD include avoidance of hepatotoxins and aggressive management of associated conditions, such as hypertriglyceridemia and type 2 diabetes mellitus.

UR - http://www.scopus.com/inward/record.url?scp=0038142845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038142845&partnerID=8YFLogxK

U2 - 10.1001/jama.289.22.3000

DO - 10.1001/jama.289.22.3000

M3 - Article

C2 - 12799409

AN - SCOPUS:0038142845

VL - 289

SP - 3000

EP - 3004

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 22

ER -